PISCATAWAY, N.J., Feb. 07, 2018 -- Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that Rutgers New Jersey Medical School has selected Alpha Clinical Systems’ cloud-based ACS360 eSource platform for clinical trial data capture.
Alpha Clinical Systems will provide the fully-integrated ACS360 platform, including Study Designer, ez-SourceDocx and Study Monitor, providing web-based study design, tablet-based direct eSource data capture and real-time, remote access to study data. The ACS360 platform is designed to help streamline study operations by providing truly paperless data capture and real-time access to validated study data, dramatically reducing study timelines and costs.
About Alpha Clinical Systems
Founded in 2009, Alpha Clinical Systems (ACS) is the leading provider of affordable and comprehensive next-generation eSource solutions. Developers of ACS360, a fully-integrated, cloud-based platform that provides direct eSource data capture with or without existing EDC systems. Working with small to mid-side sites, sponsors and CROs, Alpha Clinical Systems is dedicated to facilitating more widespread eSource adoption among life sciences companies. For more information visit us online at alphaclinicalsystems.com.
Media Contact: Alicia Maguire, Alpha Clinical Systems | 267.319.2093 | [email protected]


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



